Search

Syed Taha Iqbal

Examiner (ID: 5838, Phone: (571)270-5857 , Office: P/1736 )

Most Active Art Unit
1736
Art Unit(s)
1793, 1736
Total Applications
941
Issued Applications
713
Pending Applications
67
Abandoned Applications
178

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15264839 [patent_doc_number] => 20190381153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => BOTULINUM NEUROTOXINS WITH MODIFIED LIGHT CHAIN SPECIFITY AND METHODS FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 16/557450 [patent_app_country] => US [patent_app_date] => 2019-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6614 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557450 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/557450
Botulinum neurotoxins with modified light chain specificity and methods for producing same Aug 29, 2019 Issued
Array ( [id] => 15290777 [patent_doc_number] => 20190388524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => TREATMENT AND DETECTION OF TRYPANOSOMES [patent_app_type] => utility [patent_app_number] => 16/503687 [patent_app_country] => US [patent_app_date] => 2019-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11476 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16503687 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/503687
TREATMENT AND DETECTION OF TRYPANOSOMES Jul 4, 2019 Abandoned
Array ( [id] => 17329275 [patent_doc_number] => 11219717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-11 [patent_title] => Botulinum toxin prefilled plastic syringe [patent_app_type] => utility [patent_app_number] => 16/459382 [patent_app_country] => US [patent_app_date] => 2019-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11432 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459382 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/459382
Botulinum toxin prefilled plastic syringe Jun 30, 2019 Issued
Array ( [id] => 17236872 [patent_doc_number] => 11180744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-23 [patent_title] => Acinetobacter lysins [patent_app_type] => utility [patent_app_number] => 16/454045 [patent_app_country] => US [patent_app_date] => 2019-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 37 [patent_no_of_words] => 12973 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454045 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/454045
Acinetobacter lysins Jun 25, 2019 Issued
Array ( [id] => 15035585 [patent_doc_number] => 20190328797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES, COMPRISING BACTEROIDES ACIDIFACIENS AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 16/443501 [patent_app_country] => US [patent_app_date] => 2019-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443501 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/443501
Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient Jun 16, 2019 Issued
Array ( [id] => 14990937 [patent_doc_number] => 20190314426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS [patent_app_type] => utility [patent_app_number] => 16/427899 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427899 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/427899
Human-derived bacteria that induce proliferation or accumulation of regulatory T cells May 30, 2019 Issued
Array ( [id] => 14926351 [patent_doc_number] => 20190298813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY [patent_app_type] => utility [patent_app_number] => 16/416758 [patent_app_country] => US [patent_app_date] => 2019-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16416758 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/416758
PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY May 19, 2019 Abandoned
Array ( [id] => 16414724 [patent_doc_number] => 10822601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Methods for producing multiple recombinant polypeptides in a filamentous fungal host cell [patent_app_type] => utility [patent_app_number] => 16/394951 [patent_app_country] => US [patent_app_date] => 2019-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 53193 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394951 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/394951
Methods for producing multiple recombinant polypeptides in a filamentous fungal host cell Apr 24, 2019 Issued
Array ( [id] => 14994451 [patent_doc_number] => 20190316183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE [patent_app_type] => utility [patent_app_number] => 16/390575 [patent_app_country] => US [patent_app_date] => 2019-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390575 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/390575
FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE Apr 21, 2019 Abandoned
Array ( [id] => 16650002 [patent_doc_number] => 10927165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Antibodies that neutralize botulinum neurotoxins [patent_app_type] => utility [patent_app_number] => 16/389705 [patent_app_country] => US [patent_app_date] => 2019-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 13 [patent_no_of_words] => 40139 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16389705 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/389705
Antibodies that neutralize botulinum neurotoxins Apr 18, 2019 Issued
Array ( [id] => 15724323 [patent_doc_number] => 10610576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-07 [patent_title] => Precision glycoconjugates as therapeutic tools [patent_app_type] => utility [patent_app_number] => 16/362363 [patent_app_country] => US [patent_app_date] => 2019-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 57 [patent_no_of_words] => 28703 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362363 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/362363
Precision glycoconjugates as therapeutic tools Mar 21, 2019 Issued
Array ( [id] => 14566919 [patent_doc_number] => 20190211066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 16/360085 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360085 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/360085
VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS Mar 20, 2019 Abandoned
Array ( [id] => 14808779 [patent_doc_number] => 20190270999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => METHOD FOR MODULATING GENE EXPRESSION BY MODIFYING THE CPG CONTENT [patent_app_type] => utility [patent_app_number] => 16/298715 [patent_app_country] => US [patent_app_date] => 2019-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12222 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298715 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/298715
METHOD FOR MODULATING GENE EXPRESSION BY MODIFYING THE CPG CONTENT Mar 10, 2019 Abandoned
Array ( [id] => 14682369 [patent_doc_number] => 20190240299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => Suture Line Administration Technique Using Botulinum Toxins [patent_app_type] => utility [patent_app_number] => 16/291383 [patent_app_country] => US [patent_app_date] => 2019-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14673 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16291383 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/291383
Suture line administration technique using botulinum toxins Mar 3, 2019 Issued
Array ( [id] => 17490630 [patent_doc_number] => 11279922 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Delivery of therapeutic agents by a collagen binding protein [patent_app_type] => utility [patent_app_number] => 16/283468 [patent_app_country] => US [patent_app_date] => 2019-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 52 [patent_no_of_words] => 14262 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283468 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/283468
Delivery of therapeutic agents by a collagen binding protein Feb 21, 2019 Issued
Array ( [id] => 17307332 [patent_doc_number] => 11208424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 16/274822 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19471 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274822 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/274822
None Feb 12, 2019 Issued
Array ( [id] => 15321163 [patent_doc_number] => 20200000911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => IMMUNOGENIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/268287 [patent_app_country] => US [patent_app_date] => 2019-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268287 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/268287
IMMUNOGENIC COMPOSITION Feb 4, 2019 Abandoned
Array ( [id] => 16695514 [patent_doc_number] => 10946083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Anti-microbial immunomodulation [patent_app_type] => utility [patent_app_number] => 16/264040 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 35747 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264040 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/264040
Anti-microbial immunomodulation Jan 30, 2019 Issued
Array ( [id] => 14621841 [patent_doc_number] => 20190224288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => THERAPEUTIC USE OF THE BOTULINUM NEUROTOXIN SEROTYPE A [patent_app_type] => utility [patent_app_number] => 16/252972 [patent_app_country] => US [patent_app_date] => 2019-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5149 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252972 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/252972
Therapeutic use of the botulinum neurotoxin serotype A Jan 20, 2019 Issued
Array ( [id] => 16695517 [patent_doc_number] => 10946086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Group B [patent_app_type] => utility [patent_app_number] => 16/245378 [patent_app_country] => US [patent_app_date] => 2019-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 47493 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245378 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/245378
Group B Jan 10, 2019 Issued
Menu